The weekly litigation news digest is live. Subscribe now

IP Verse

N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof - EP3632907

The patent EP3632907 was granted to Abbisko Therapeutics on Feb 28, 2024. The application was filed on May 22, 2018 under application number EP18805288A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3632907

ABBISKO THERAPEUTICS
Application Number
EP18805288A
Filing Date
May 22, 2018
Status
Granted And Under Opposition
Jan 26, 2024
Publication Date
Feb 28, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
DECIPHERA PHARMACEUTICALSNov 13, 2024MARKS & CLERKADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2006067445
INTERNATIONAL-SEARCH-REPORTWO2014145015
INTERNATIONAL-SEARCH-REPORTWO2014145023
INTERNATIONAL-SEARCH-REPORTWO2014145028
OPPOSITIONWO2014145015
OPPOSITIONWO2014145028
OTHERWO2014145028

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents